{"id":"W2530836433","doi":"10.1200/jco.2006.24.18_suppl.8562","title":"A randomized trial of denosumab (AMG 162) versus intravenous (IV) bisphosphonates (BP) in cancer patients (pts) with bone metastases (BM) on established IV BP and evidence of elevated bone resorption","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"Toronto East General Hospital","funders":"","keywords":"Medicine; Denosumab; Bone resorption; Zoledronic acid; Internal medicine; Urology; Clinical endpoint; Creatinine; Gastroenterology; Randomized controlled trial; Osteoporosis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low","status":"direct model label, unvalidated"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low","status":"direct model label, unvalidated"}],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001827644,0.002420591,0.003409182,0.0004915049,0.0004208217,0.001308068,0.001123768,0.001999267,0.008925955],"category_scores_gemma":[0.00246293,0.001021147,0.001622253,0.0004715745,0.001473544,0.001350684,0.0006311644,0.003534015,0.001610579],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006691343,"about_ca_system_score_gemma":0.001371111,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008759784,"about_ca_topic_score_gemma":0.001855387,"domain_scores_codex":[0.9991633,0.000517719,0.00004208533,0.0001229792,0.00004300856,0.0001110541],"domain_scores_gemma":[0.9985696,0.0003844752,0.0003055508,0.0001235119,0.0000678808,0.0005489446],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9904742,0.004332798,0.000196344,0.0001229235,0.0001801957,0.00001521934,0.0000183382,0.0001437975,0.001160831,0.000038667,0.0001947654,0.003121967],"study_design_scores_gemma":[0.936014,0.06260666,0.0005298658,0.00001069431,0.0001332684,0.00001349431,0.0000105648,0.0002555048,0.0001530749,0.0000821129,0.000184639,0.000006155831],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9881639,0.001439572,0.0006673551,0.000744433,0.0006072722,0.005367987,0.001098485,0.0001421049,0.001768947],"genre_scores_gemma":[0.9832138,0.001239808,0.001648569,0.00121874,0.0006487465,0.006991128,0.00127017,0.00003001854,0.00373907],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008925955,"threshold_uncertainty_score":0.02986026,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09097436862594893,"score_gpt":0.4343519451164578,"score_spread":0.3433775764905089,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}